coronary artery disease

Medtronic lands option to buy artery disease player CathWorks for up to $585M
Medtech Dive
Wed, 07/13/22 - 10:04 am
devices
Medtech
Medtronic
CathWorks
M&A
coronary artery disease
Abbott's research initiative finds gap between perceived and actual patient experience in vascular care
Fierce Pharma
Wed, 12/15/21 - 10:46 am
Medtech
R&D
devices
Abbott Labs
Abbott Vascular
coronary artery disease
AZ claims FDA okay for Brilinta in coronary artery disease patients
Pharmaforum
Tue, 06/2/20 - 10:48 am
AstraZeneca
Brilinta
FDA
heart attacks
stroke
coronary artery disease
Idorsia's selatogrel hits goals in phase 2 cardiovascular trials
Fierce Biotech
Tue, 12/18/18 - 10:37 am
Idorsia
selatogrel
clinical trials
coronary artery disease
acute myocardial infarctions
J&J's Xarelto pads artery disease case by reducing amputation, death rates vs. aspirin
Fierce Pharma
Thu, 11/16/17 - 09:41 am
JNJ
Xarelto
blood thinners
PAD
coronary artery disease
Bayer's blood thinner also effective for artery disease
Yahoo/Reuters
Wed, 02/8/17 - 09:34 pm
Bayer
bloodthinners
Xarelto
peripheral artery disease
coronary artery disease
Abbott wins FDA nod for Absorb stent
Mass Device
Tue, 07/5/16 - 09:42 pm
Abbott Labs
Absorb stent
FDA
devices
coronary artery disease
DiaDexus: A Hearty Choice
Seeking Alpha
Mon, 09/9/13 - 09:42 am
diaDexus
coronary artery disease
GSK
PLAC ELISA Test
diagnostics
devices
Stereotaxis Announces Global Initial Training Site at University of Chicago
Thu, 12/30/10 - 03:58 pm
Stereotaxis
training
chicago
coronary artery disease
arrhythmias
Stereotaxis sells 600,000 shares for $2M
Thu, 12/2/10 - 09:56 pm
Stereotaxis
arrhythmias
coronary artery disease
stocks
Volcano Reports 35 Percent Increase in Third Quarter Revenues
Fri, 11/5/10 - 12:01 pm
Volcano Corporation
intravascular diagnosis
coronary artery disease
Stereotaxis Awarded $1.5 Million in Grants under the Qualifying Therapeutic Discovery Project Program
Thu, 11/4/10 - 08:35 am
Stereotaxis
grants
coronary artery disease
arrhythmias
cardiology
Stereotaxis Announces Third Quarter 2010 Capital Orders of $12.2 Million, Up 94 Percent Year-to-Year
Wed, 10/13/10 - 11:17 pm
Stereotaxis
Niobe
Odyssey
coronary artery disease
arrhythmias
Medtronic Studies DEB Therapy
Fri, 10/1/10 - 07:59 am
Medtronic
coronary artery disease
peripheral artery disease
balloon expandable stent
cardiology